Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Gains from Investment Securities (2016 - 2025)

Xtant Medical Holdings has reported Gains from Investment Securities over the past 12 years, most recently at $70000.0 for Q4 2025.

  • Quarterly Gains from Investment Securities rose 233.33% to $70000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $124000.0 through Dec 2025, up 126.22% year-over-year, with the annual reading at $121000.0 for FY2025, 96.92% down from the prior year.
  • Gains from Investment Securities was $70000.0 for Q4 2025 at Xtant Medical Holdings, down from $3.8 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $3.8 million in Q2 2025 and troughed at -$525000.0 in Q4 2023.
  • The 5-year median for Gains from Investment Securities is $98006.5 (2022), against an average of $602107.3.
  • Year-over-year, Gains from Investment Securities skyrocketed 354400.0% in 2022 and then crashed 3600.0% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $8000.0 in 2021, then skyrocketed by 87.5% to $15000.0 in 2022, then crashed by 3600.0% to -$525000.0 in 2023, then surged by 104.0% to $21000.0 in 2024, then surged by 233.33% to $70000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Gains from Investment Securities are $70000.0 (Q4 2025), $3.8 million (Q3 2025), and $3.8 million (Q2 2025).